Seres Therapeutics, Inc.MCRBNASDAQ
Loading
Year-over-year net income growth rate
Percentile
P3
Near historical low
vs 5Y Ago
-7.2x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -286.92% |
| Q3 2025 | 141.32% |
| Q2 2025 | -160.75% |
| Q1 2025 | 309.00% |
| Q4 2024 | -117.61% |
| Q3 2024 | 370.08% |
| Q2 2024 | 18.10% |
| Q1 2024 | 2.70% |
| Q4 2023 | 13.80% |
| Q3 2023 | -202.80% |
| Q2 2023 | 165.41% |
| Q1 2023 | -3.46% |
| Q4 2022 | -14.66% |
| Q3 2022 | 7.31% |
| Q2 2022 | -14.32% |
| Q1 2022 | -13.25% |
| Q4 2021 | -173.30% |
| Q3 2021 | 241.15% |
| Q2 2021 | -36.28% |
| Q1 2021 | -94.31% |
| Q4 2020 | 39.72% |
| Q3 2020 | -46.18% |
| Q2 2020 | -4.19% |
| Q1 2020 | -5.87% |
| Q4 2019 | -14.44% |
| Q3 2019 | -52.51% |
| Q2 2019 | 55.78% |
| Q1 2019 | -14.31% |
| Q4 2018 | 3.02% |
| Q3 2018 | 21.01% |
| Q2 2018 | 0.47% |
| Q1 2018 | 3.57% |
| Q4 2017 | -317.49% |
| Q3 2017 | 75.25% |
| Q2 2017 | -9.99% |
| Q1 2017 | -0.78% |
| Q4 2016 | -35.25% |
| Q3 2016 | 33.05% |
| Q2 2016 | -41.66% |
| Q1 2016 | -0.36% |